References
- Kilroy AC, Gray NF. The toxicity of four organic solvents commonly used in the pharmaceutical industry to activated sludge. Water Res. 1992;26:887–892. doi: https://doi.org/10.1016/0043-1354(92)90193-8
- Ternes TA, Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers 1. Water Res. 1998;32:3245–3260. doi: https://doi.org/10.1016/S0043-1354(98)00099-2
- Oaks JL, Gilbert M, Virani MZ, et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature. 2004;427:630–633. doi: https://doi.org/10.1038/nature02317
- Pomati F, Castiglioni S, Zuccato E, et al. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ Sci Technol. 2006;40:2442–2447. doi: https://doi.org/10.1021/es051715a
- Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Br Dent J. 2013;382:289–289.
- Acuña V, Ginebreda A, Mor JR, et al. Balancing the health benefits and environmental risks of pharmaceuticals: diclofenac as an example. Environ Int. 2015;85:327–333. doi: https://doi.org/10.1016/j.envint.2015.09.023
- European Community, Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy. Off J Eur Union. 2013, L 226.
- U.S. Environmental Protection Agency. Water: contaminant candidate list 3 e CCL; 2012. Available from: http://water.epa.gov/scitech/drinkingwater/dws/ccl/ccl3.cfm
- GWRC (Global Water Research Coalition). Development of an international priority list of pharmaceuticals relevant for the water cycle. Prepared by Kiwa Water Research, CIRSEE and TZW, 2008. [cited 2016 Jul 29]. Available from: http://edepot.wur.nl/138086
- European Commission, Implementing Decision 2015/495 of 20 March 2015 Establishing a watch list of substances for union-wide monitoring in the field of water policy pursuant to directive 2008/105/EC and amending directive 2000/60/EC.
- Gros M, Petrovic M, Ginebreda A, et al. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int. 2010;36:15–26. doi: https://doi.org/10.1016/j.envint.2009.09.002
- Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment – a review. Sci Total Environ. 2012;429:123–155. doi: https://doi.org/10.1016/j.scitotenv.2012.04.028
- Liu JL, Wong MH. Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ Int. 2013;59:208–224. doi: https://doi.org/10.1016/j.envint.2013.06.012
- Mohapatra S, Huang CH, Mukherji S, et al. Occurrence and fate of pharmaceuticals in WWTPs in India and comparison with a similar study in the United States. Chemosphere. 2016;159:526–535. doi: https://doi.org/10.1016/j.chemosphere.2016.06.047
- And GAL, Pettigrove ME. Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in southern California. Environ Sci Technol. 2006;40:687–695. doi: https://doi.org/10.1021/es051380x
- Sun Z, Qin SJ, Singhal A, et al. Long-term comparison of trace organics removal performances between conventional and membrane activated sludge processes. Water Environ Res. 2006;78:2480–2486. doi: https://doi.org/10.2175/106143006X111826
- Silva LJG, Pereira AMPT, Meisel LM, et al. A one-year follow-up analysis of antidepressants in Portuguese wastewaters: occurrence and fate, seasonal influence, and risk assessment. Sci Total Environ. 2014;490:279–287. doi: https://doi.org/10.1016/j.scitotenv.2014.04.131
- Papageorgiou M, Kosma C, Lambropoulou D. Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater treatment plant in central Greece. Sci Total Environ. 2016;543(Part A):547–569. doi: https://doi.org/10.1016/j.scitotenv.2015.11.047
- Xu W, Zhang G, Li X, et al. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), south China. Water Res. 2007;41:4526–4534. doi: https://doi.org/10.1016/j.watres.2007.06.023
- Zheng Q, Zhang R, Wang Y, et al. Occurrence and distribution of antibiotics in the Beibu Gulf, China: impacts of river discharge and aquaculture activities. Mar Environ Res. 2012;78:26–33. doi: https://doi.org/10.1016/j.marenvres.2012.03.007
- Sui Q, Huang J, Deng S, et al. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res. 2010;44:417–426. doi: https://doi.org/10.1016/j.watres.2009.07.010
- Yan Q, Gao X, Huang L, et al. Occurrence and fate of pharmaceutically active compounds in the largest municipal wastewater treatment plant in Southwest China: mass balance analysis and consumption back-calculated model. Chemosphere. 2014;99:160–170. doi: https://doi.org/10.1016/j.chemosphere.2013.10.062
- Sui Q, Huang J, Deng S, et al. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ Sci Technol. 2011;45:3341–3348. doi: https://doi.org/10.1021/es200248d
- Sun Q, Lv M, Hu A, et al. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in a wastewater treatment plant in Xiamen, China. J Hazard Mater. 2014;277:69–75. doi: https://doi.org/10.1016/j.jhazmat.2013.11.056
- APHA. Standard methods for the examination of water and wastewater. 22nd ed. Washington (DC): American Public Health Association; 2012.
- Zhao JL, Ying GG, Wang L, et al. Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry. Sci Total Environ. 2009;407:962–974. doi: https://doi.org/10.1016/j.scitotenv.2008.09.048
- Gleit A. Estimation for small normal data sets with detection limits. Environ Sci Technol. 1985;19:1201–1206. doi: https://doi.org/10.1021/es00142a011
- Reemtsma T, Weiss S, Mueller J, et al. Polar pollutants entry into the water cycle by municipal wastewater: a European perspective. Environ Sci Technol. 2006;40:5451–5458. doi: https://doi.org/10.1021/es060908a
- Gao P, Ding Y, Li H, et al. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes. Chemosphere. 2012;88:17–24. doi: https://doi.org/10.1016/j.chemosphere.2012.02.017
- Al-Rifai JH, Khabbaz H, Schäfer AI. Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems. Sep Purif Technol. 2011;77:60–67. doi: https://doi.org/10.1016/j.seppur.2010.11.020
- Kosma CI, Lambropoulou DA, Albanis TA. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J Hazard Mater. 2010;179:804–817. doi: https://doi.org/10.1016/j.jhazmat.2010.03.075
- Vanderford BJ, Snyder SA. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol. 2006;40:7312–7320. doi: https://doi.org/10.1021/es0613198
- Lishman L, Smyth SA, Sarafin K, et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ. 2006;367:544–558. doi: https://doi.org/10.1016/j.scitotenv.2006.03.021
- Ockene IS, Chiriboga DE, Harmatz MG, et al. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med. 2004;164:863–870. doi: https://doi.org/10.1001/archinte.164.8.863
- Marketing research report on antilipidemic in 2005. Guangzhou, China: China Medicine Economic Information Net (CMEIN); 2005.
- Clara M, Kreuzinger N, Strenn B, et al. The solids retention time – a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 2005;39:97–106. doi: https://doi.org/10.1016/j.watres.2004.08.036
- Joss A, Keller E, Alder AC, et al. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005;39:3139–3152. doi: https://doi.org/10.1016/j.watres.2005.05.031
- Jelic A, Gros M, Ginebreda A, et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011;45:1165–1176. doi: https://doi.org/10.1016/j.watres.2010.11.010
- Cirja M, Ivashechkin P, Schäffer A, et al. Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR). Rev Environ Sci Bio. 2008;7:61–78. doi: https://doi.org/10.1007/s11157-007-9121-8
- Quintana JB, Weiss S, Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005;39:2654–2664. doi: https://doi.org/10.1016/j.watres.2005.04.068
- Xue W, Wu C, Xiao K, et al. Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Res. 2010;44:5999–6010. doi: https://doi.org/10.1016/j.watres.2010.07.052
- Suarez S, Lema JM, Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res. 2010;44:3214–3224. doi: https://doi.org/10.1016/j.watres.2010.02.040
- Tang Y, Li XM, Xu ZC, et al. Removal of naproxen and bezafibrate by activated sludge under aerobic conditions: kinetics and effect of substrates. Biotechnol Appl Biochem. 2014;61:333–341. doi: https://doi.org/10.1002/bab.1187
- Hong C, Hu JY, Wang LZ, et al. Occurrence of sulfonamide antibiotics in sewage treatment plants. Chin Sci Bull. 2008;53:514–520. doi: https://doi.org/10.1007/s11434-008-0123-x
- Sipma J, Osuna B, Collado N, et al. Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination. 2010;250:653–659. doi: https://doi.org/10.1016/j.desal.2009.06.073
- Radjenovic J, Petrovic M, Barcel D. Advanced mass spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment. TrAC Trends Analyt Chem. 2007;26:1132–1144. doi: https://doi.org/10.1016/j.trac.2007.10.002
- Vieno N, Tuhkanen T, Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res. 2007;41:1001–1012. doi: https://doi.org/10.1016/j.watres.2006.12.017
- Santos JL, Aparicio I, Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville City (Spain). Environ Int. 2007;33:981–987. doi: https://doi.org/10.1016/j.envint.2006.09.014
- European Commission, Technical Guidance Document in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Part II, Brussels, Belgium, 2003.
- Zhao JL, Ying GG, Liu YS, et al. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. In: SETAC AP; 2010. p. 1377–1384.
- Hernando MD, Mezcua M, Fernández-Alba AR, et al. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta. 2006;69:334–342. doi: https://doi.org/10.1016/j.talanta.2005.09.037
- Pomati F, Orlandi C, Clerici M, et al. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci. 2008;102:129–137. doi: https://doi.org/10.1093/toxsci/kfm291
- Yang LH, Ying GG, Su HC, et al. Growth-inhibiting effects of 12 antibacterial agents and their mixtures on the freshwater microalga Pseudokirchneriella subcapitata. Environ Toxicol Chem. 2008;27:1201–1208. doi: https://doi.org/10.1897/07-471.1
- Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett. 2003;142:185–194. doi: https://doi.org/10.1016/S0378-4274(03)00068-7